|
|
Clinical Trials
Clinical Trials
A MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF A COMBINATION ORAL CONTRACEPTIVE REGIMEN (DR-102) FOR THE PREVENTION OF PREGNANCY IN WOMEN (Protocol #: DSG-PPS-303)
Keywords: Contraception, Birth conrol | A Phase 3, Twelve-Week, Multicenter, Double-Blind, Randomized, Placebo-Controlled,
Efficacy and Safety Study of Mesafem (Paroxetine Mesylate) Capsules in the Treatment of
Vasomotor Symptoms Associated with Menopause (N30-003)
Keywords: Menopause | An Open-Label, Randomized, Parallel Group, Phase 3 Study of the Contraceptive Efficacy and Safety of Agile Transdermal Contraceptive Delivery System (TCDS) in Comparison to a Low-Dose Oral Contraceptive Containing 0.02mg Ethinyl Estradiol and 0.1mg Levenorgestrel in a 21-day Regimen (ATI-CL12)
Keywords: Birth Control, Contraception | Evaluation of Biomarkers for the Detection and Monitoring of Cervical Cancer
Keywords: Cervical dysplasia | Multi-Center, open-label, randomized study to assess the safety and contraceptive efficacy of two doses (in vitro 12 µg/24 h and 16 µg/24 h) of the low dose levonorgestrel contraceptive intrauterine systems (LCS) for a maximum of 3 years in women 18 to 35 years of age (#310442)
Keywords: Birth Control, IUD |
All Research
A MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF A COMBINATION ORAL CONTRACEPTIVE REGIMEN (DR-102) FOR THE PREVENTION OF PREGNANCY IN WOMEN (Protocol #: DSG-PPS-303)
Keywords: Contraception, Birth conrol | A Phase 3, Twelve-Week, Multicenter, Double-Blind, Randomized, Placebo-Controlled,
Efficacy and Safety Study of Mesafem (Paroxetine Mesylate) Capsules in the Treatment of
Vasomotor Symptoms Associated with Menopause (N30-003)
Keywords: Menopause | An Open-Label, Randomized, Parallel Group, Phase 3 Study of the Contraceptive Efficacy and Safety of Agile Transdermal Contraceptive Delivery System (TCDS) in Comparison to a Low-Dose Oral Contraceptive Containing 0.02mg Ethinyl Estradiol and 0.1mg Levenorgestrel in a 21-day Regimen (ATI-CL12)
Keywords: Birth Control, Contraception | DHEA Against Vaginal Atrophy - Safety Study of 12 Months (Protocol ERC-230)
Keywords: Vaginal atrophy, Post Menopause | DHEA Against Vaginal Dryness (Placebo-Controlled, Double-Blind and Randomized Phase III Study of 3-Month Intravaginal DHEA)
Keywords: Vaginal Dryness | Do Uterine Leiomyomata Cause Postmenopausal Bleeding? A Cross-sectional Study
Keywords: Uterine Leiomyomata | Evaluation of Biomarkers for the Detection and Monitoring of Cervical Cancer
Keywords: Cervical dysplasia | FAST Exam in the pregnant trauma patient: a retrospective registry review and chart review
Keywords: Pregnancy, Trauma, FAST | Multi-Center, open-label, randomized study to assess the safety and contraceptive efficacy of two doses (in vitro 12 µg/24 h and 16 µg/24 h) of the low dose levonorgestrel contraceptive intrauterine systems (LCS) for a maximum of 3 years in women 18 to 35 years of age (#310442)
Keywords: Birth Control, IUD |
|
|
Kelly Best, M.D. - Human Papillomavirus